Skip to main content

    Chris Garabedian

    Portfolio Manager, Venture (PXV Fund)

    Perceptive Advisors
    Boston, Massachusetts, United States
    18 investments

    Chris Garabedian is a Portfolio Manager, Venture (PXV Fund) at Perceptive Advisors based in Boston, Massachusetts, United States. Chris Garabedian has backed 18 companies, including Tellus Therapeutics, Nephraegis Therapeutics and CereVasc. Investment focus areas include Health Care, Autoimmune Diseases and Biotech.

    Sign up to access email, LinkedIn & portfolio

    Portfolio Companies (9)

    1Tellus Therapeutics
    2Nephraegis Therapeutics
    3CereVasc
    4Landos Biopharma
    5Juno Diagnostics
    6Peroxitech Therapeutics
    7Zucara Therapeutics
    8AsclepiX Therapeutics
    9Shifa Biomedical
    Showing 1–9 of 9

    Access Full Contact Information

    Get Chris Garabedian's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.

    Email
    LinkedIn
    Portfolio

    3-day free trial, cancel anytime

    Raising a round? Run your numbers first

    Free tools founders use before pitching investors like this one.